Europe's first CAR-T Congress| 30 - 31 Jan 2018

30/11/2017 - 31/01/2018 Berlin, Germany

A Collaborative Approach to Maximize the Potential of CAR-T

CAR-T clinical trials have demonstrated unparalleled success achieving remission rates of up to 94% in multiple hematological malignancies…is CAR-T therapy what we’ve been waiting for?

Join 18+ thought-leaders from biotech, big pharma, academia and the wider service community on 30th – 31st January 2018 at Europe’s first congress dedicated to addressing the challenges and opportunities of CAR-T therapies.

  • Hear first-hand results from unpublished human and clinical studies
  • Explore the challenges of the tumour microenvironment
  • Understand how to implement a combined approach to cell therapy
  • Discover safety switch improvement strategies
  • Network with 100+ attendees to share knowledge and understand the commercial opportunities of CAR-T

With a 50:50 split of academia to industry, build relationships whilst being updated by 20+ amazing speakers from University Hospital of Cologne, Catapult, Cellectis and more on all of the latest developments in this exciting field.  Get involved today.

Find out more